Table A1.
Medline Search Strategya
| Study design |
| 1. clinical trial.pt |
| 2. clinical trial, phase I.pt |
| 3. clinical trial, phase II.pt |
| 4. clinical trial, phase III.pt |
| 5. clinical trial, phase IV.pt |
| 6. controlled clinical trial.pt |
| 7. randomized controlled trial.pt |
| 8. random* |
| General diagnosis |
| 9. arthriti**, ti, ab |
| 10. arthro**, ti, ab |
| 11. gonarthriti**, ti, ab |
| 12. gonarthro**, ti, ab |
| 13. osteoarthriti*, ti, ab |
| 14. osteoarthritis, majr |
| 15. osteoarthro**, ti, ab |
| Diagnosis location |
| 16. knee, mp |
| Hyaluronic acid |
| 17. adant, mp |
| 18. arthrum, mp |
| 19. artz*, mp |
| 20. biohy, mp |
| 21. durolane, mp |
| 22. euflexxa, mp |
| 23. gel-one, mp |
| 24. gelsyn*, mp |
| 25. healon, mp |
| 26. hya-ject, mp |
| 27. hyalectin, mp |
| 28. hyalgan, mp |
| 29. hyaluron*, mp |
| 30. hylan, mp |
| 31. hymovis, mp |
| 32. monovisc, mp |
| 33. nrd101, mp |
| 34. nuflexxa, mp |
| 35. orthovisc, mp |
| 36. ostenil, mp |
| 37. supartz, mp |
| 38. suplasyn, mp |
| 39. synojoint, mp |
| 40. synvisc*, mp |
| 41. trivisc, mp |
| 42. viscosupplement*, mp |
| 43. visco-3, mp |
| Nonsteroidal anti-inflammatory drugs |
| 44. aspirin |
| 45. celebrex |
| 46. celecoxib |
| 47. cox-2 |
| 48. diclofenac |
| 49. diflunisal |
| 50. etodolac |
| 51. fenoprofen |
| 52. ibuprofen |
| 53. indomethacin |
| 54. ketoprofen |
| 55. meclofenamate |
| 56. mefanamic |
| 57. meloxicam |
| 58. nabumetone |
| 59. naproxen |
| 60. nonsteroidal anti-inflammatory drug |
| 61. NSAID |
| 62. oxaprozin |
| 63. piroxicam |
| 64. sulindac |
| 65. tolmetin |
| Combination terms |
| 66. or/1-8 |
| 67. or/9-15 |
| 68. or/16 |
| 69. or/17-43 |
| 70. or/44-65 |
| 71. and/66-70 |
aAn asterisk represents wildcard end-truncation.